HAE - HAEMONETICS CORP


64.67
-0.960   -1.484%

Share volume: 783,245
Last Updated: 03-04-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%

$65.63
-0.96
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
40%
Profitability 18%
Dept financing 41%
Liquidity 34%
Performance 63%
Company vs Stock growth
vs
Performance
5 Days
1.24%
1 Month
-0.54%
3 Months
-22.96%
6 Months
18.92%
1 Year
-3.71%
2 Year
-15.46%
Key data
Stock price
$64.67
P/E Ratio 
21.42
DAY RANGE
$64.06 - $66.09
EPS 
$3.65
52 WEEK RANGE
$47.32 - $87.32
52 WEEK CHANGE
-$3.76
MARKET CAP 
3.758 B
YIELD 
N/A
SHARES OUTSTANDING 
46.471 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
1.51
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$762,229
AVERAGE 30 VOLUME 
$1,009,906
Company detail
CEO: Christopher A. Simon
Region: US
Website: haemonetics.com
Employees: 2,820
IPO year: 1991
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Haemonetics Corporation provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software. It also provides automated blood component and manual whole blood collection systems.

Recent news